BioPharma Credit PLC (BPCR.L)
USD 0.89
(0.91%)
USD 0.89
(0.91%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 15.87 Million USD | -39.66% |
| 2022 | 26.3 Million USD | 314.71% |
| 2021 | 6.34 Million USD | -32.48% |
| 2020 | 9.39 Million USD | -62.78% |
| 2019 | 25.23 Million USD | 90.44% |
| 2018 | 13.25 Million USD | 354.42% |
| 2017 | 2.91 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 3.53 Million USD | 0.0% |
| 2024 Q1 | 3.53 Million USD | -77.73% |
| 2023 Q1 | 4.94 Million USD | -81.21% |
| 2023 FY | 15.87 Million USD | -39.66% |
| 2023 Q4 | 15.87 Million USD | 0.0% |
| 2023 Q3 | 15.87 Million USD | 221.21% |
| 2023 Q2 | 4.94 Million USD | 0.0% |
| 2022 Q2 | 4.41 Million USD | 10.27% |
| 2022 FY | 26.3 Million USD | 314.71% |
| 2022 Q4 | 26.3 Million USD | 0.0% |
| 2022 Q3 | 26.3 Million USD | 495.99% |
| 2022 Q1 | 4 Million USD | -42.0% |
| 2021 Q4 | 6.9 Million USD | 8.8% |
| 2021 Q3 | 6.34 Million USD | 65.93% |
| 2021 Q2 | 3.82 Million USD | 0.0% |
| 2021 FY | 6.34 Million USD | -32.48% |
| 2021 Q1 | 3.82 Million USD | -59.31% |
| 2020 Q4 | 9.39 Million USD | 0.0% |
| 2020 Q2 | 31.93 Million USD | 1.8% |
| 2020 FY | 9.39 Million USD | -62.78% |
| 2020 Q1 | 31.37 Million USD | 24.32% |
| 2020 Q3 | 9.39 Million USD | -70.59% |
| 2019 Q3 | 24.5 Million USD | 109.47% |
| 2019 Q4 | 25.23 Million USD | 2.98% |
| 2019 Q2 | 11.69 Million USD | 199.64% |
| 2019 Q1 | 3.9 Million USD | -70.54% |
| 2019 FY | 25.23 Million USD | 90.44% |
| 2018 Q2 | 164.01 Million USD | 0.0% |
| 2018 FY | 13.25 Million USD | 354.42% |
| 2018 Q4 | 13.25 Million USD | 142.83% |
| 2018 Q3 | 5.45 Million USD | -96.67% |
| 2018 Q1 | 164.01 Million USD | 5524.62% |
| 2017 FY | 2.91 Million USD | 0.0% |
| 2017 Q2 | 5.65 Million USD | 0.0% |
| 2017 Q4 | 2.91 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Ameriprise Financial, Inc. | 170.46 Billion USD | 99.991% |
| Gladstone Investment Corporation | 445.37 Million USD | 96.436% |
| Principal Financial Group, Inc. | 293.83 Billion USD | 99.995% |
| Africa Opportunity Fund Limited | 160.69 USD | -9876681.38% |
| BH Macro Limited | 3 Million USD | -428.857% |
| CATCo Reinsurance Opportunities Fund Ltd. | 2.44 Million USD | -548.431% |
| Craven House Capital Plc | 1.56 Million USD | -916.069% |
| JPEL Private Equity Limited | 623 Thousand USD | -2447.512% |
| Pershing Square Holdings, Ltd. | 3.06 Billion USD | 99.482% |
| Ecofin U.S. Renewables Infrastructure Trust PLC | 795 Thousand USD | -1896.352% |
| RTW Venture Fund Limited | 17.21 Million USD | 7.788% |
| Tufton Oceanic Assets Limited | 1.2 Million USD | -1214.317% |
| Symphony International Holdings Limited | 425 Thousand USD | -3634.353% |
| Tetragon Financial Group Limited | 250 Million USD | 93.652% |
| Taylor Maritime Investments Limited | 3.4 Million USD | -366.565% |
| TMT Investments PLC | 1.71 Million USD | -823.906% |
| Third Point Investors Limited | 333.38 Thousand USD | -4660.619% |